HTRA2 Recombinant Antibody, PerCP Conjugated
Référence bsm-61230R-PerCP
Conditionnement : 100uL
Marque : Bioss
Applications
Reactivity
| Overview | |
| Catalog # | bsm-61230r-percp |
| Product Name | HTRA2 Recombinant Antibody, PerCP Conjugated |
| Applications | WB, IF |
| Reactivity | Human, Mouse, Rat |
| Specifications | |
| Conjugation | PerCP |
| Host | Rabbit |
| Source | KLH conjugated synthetic peptide derived from human HTRA2 |
| Clonality | Recombinant |
| Isotype | IgG |
| Concentration | Lot dependent |
| Purification | Purified by Protein A. |
| Storage Buffer | Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Storage Condition | Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target | |
| Gene ID | 27429 |
| Swiss Prot | O43464 |
| Subcellular location | Cytoplasm, Cell membrane |
| Synonyms | HTRA2; HtrA-like serine protease; OMI; PARK13; Protease; PRSS25; Serine protease 25; HtrA serine peptidase 2; Serine proteinase OMI. |
| Background | Serine protease that shows proteolytic activity against a non-specific substrate beta-casein. Promotes or induces cell death either by direct binding to and inhibition of BIRC proteins (also called inhibitor of apoptosis proteins, IAPs), leading to an increase in caspase activity, or by a BIRC inhibition-independent, caspase-independent and serine protease activity-dependent mechanism. Cleaves THAP5 and promotes its degradation during apoptosis. Isoform 2 seems to be proteolytically inactive. |
| Application Dilution | |
| WB | 1:300-5000 |
| IF | |